Keywords: Amylin, Eli Lilly, Byetta, Diabetes, Anti-inflammatory effect, Buffalo University

Amylin and Lilly’s diabetes drug Byetta has rapid, powerful anti-inflammatory effect

Article | 04 November 2011

Print This

Byetta (exenatide), a drug which has been co-developed and now marketed by US biotech firm Amylin (Nasdaq: AMLN) and drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in